Ultimele actualizari :
19/11/2024
Infostab
Listele
Listele
Cercetări de compatibilitate
Tabel de compatibilitate Y-site
Bibliografie
Echipe de cercetare
valistab
poster
Conexiuni
sponsori
Autor
Mod de utilizare
Newsletter
Bibliografie 4569
tip :
ziar
Internet legătură într- :
https://doi.org/10.1177/0018578719893376
Echipe de cercetare :
La Crosse - Department of Medical Education, Gundersen HealthSystem, La Crosse, USA
Autor :
Lee T.M , Villareal C.L, Meyer L.M.
titlu :
Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
Référence :
Hosp Pharm ; 56, 4: 282-286. 2021
Nivelul dovezii :
stabilitatea fizică :
Stabilitate chimică :
alte metode :
Comentarii :
Listele
Cisatracurium besylate
1 mg/ml
+
Levetiracetam
5 mg/ml
+
Dexmedetomidine
4 µg/ml
+
Levetiracetam
5 mg/ml
+
Fosphenytoin sodium
15 mg/ml
+
Levetiracetam
5 mg/ml
+
Levetiracetam
5 mg/ml
+
Cisatracurium besylate
1 mg/ml
+
5 mg/ml
+
Dexmedetomidine
4 µg/ml
+
5 mg/ml
+
Fosphenytoin sodium
15 mg/ml
+
5 mg/ml
+
Norepinephrine bitartrate
0,016 >>0,064 mg/ml
+
5 mg/ml
+
Piperacillin sodium / tazobactam
45 mg/ml
+
5 mg/ml
+
Piperacillin sodium / tazobactam
33,75 mg/ml
+
5 mg/ml
+
Propofol
10 mg/ml
+
5 mg/ml
+
Vancomycin hydrochloride
5 mg/ml
+
5 mg/ml
+
Vasopressin
1 UI/ml
+
Norepinephrine bitartrate
0,016 >>0,064 mg/ml
+
Levetiracetam
5 mg/ml
+
Piperacillin sodium / tazobactam
45 mg/ml
+
Levetiracetam
5 mg/ml
+
33,75 mg/ml
+
Levetiracetam
5 mg/ml
+
Propofol
10 mg/ml
+
Levetiracetam
5 mg/ml
+
Vancomycin hydrochloride
5 mg/ml
+
Levetiracetam
5 mg/ml
+
Vasopressin
1 UI/ml
+
Levetiracetam
5 mg/ml
+
Mentions Légales
